No need to wear power glass now

PresVu is an eye drop recently developed by Entod Pharmaceuticals in Mumbai, designed for the treatment of presbyopia, a condition that affects near vision.

About Presbyopia

Presbyopia is a natural part of aging and affects almost everyone to some extent. The most common solutions are reading glasses, bifocals, or contact lenses. In recent years, treatments such as specialized drops like PresVu and surgical interventions have emerged as alternatives. While presbyopia cannot be completely prevented, these solutions help restore near vision and improve the quality of life for those affected.

Presbyopia typically begins to occur after the mid-forties and can worsen significantly after the age of sixty. The Drug Controller General of India (DCGI) has given final approval for the use of this drop, which is considered highly effective for treating common problems like presbyopia.

DGCI – The Drug Controller General of India approve licenses for certain drug categories, including blood and blood products, IV fluids, vaccinations, and sera.

Key ingredients of PresVu eye drop

The key active ingredient in PresVu is 1.25% pilocarpine hydrochloride, a plant-based compound. This compound has been known for its beneficial effects on various eye conditions and has long been used in eye care.

Pilocarpine is particularly effective in controlling intraocular pressure, making it a valuable addition to the formula of PresVu, which aims to provide a more effective treatment for presbyopia.

PresVu- a new eye drop

Presbyopia is mainly caused by aging. Until now, the only treatments for this issue were power glasses, contact lenses, or surgery. However, the introduction of PresVu opens up new possibilities, offering a non-invasive solution that can correct presbyopia without the need for glasses or surgery.

PresVu represents a groundbreaking innovation in eye care, especially for those who begin to experience declining vision in their forties. With its use, individuals can regain their normal vision, improving the quality of their daily lives.

This product offers a new approach to eye treatment that could reduce dependence on glasses and bring positive changes to people’s lifestyles.

This eye drop is particularly beneficial for individuals who are uncomfortable wearing glasses or contact lenses. It reduces eye discomfort or strain, helping patients regain their normal vision.

As medical science continues to advance, innovations like PresVu demonstrate that effective, medication-based solutions for eye problems are becoming increasingly popular.

The ease of use and the absence of a need for glasses or surgery make PresVu a convenient choice for patients. It also offers a more cost-effective way to manage presbyopia.

The use of pilocarpine, a plant-derived compound, is a key feature of PresVu, as it is natural and causes fewer side effects. This makes it safer for long-term use.

Pilocarpine works by stimulating the eye muscles and improving the elasticity of the eye lens, helping restore the eye’s normal functionality. As a result, individuals with presbyopia can more easily perform everyday tasks such as reading, using a mobile phone, or seeing small text.

In addition to treating presbyopia, PresVu can also be used for other optical conditions. It is especially effective in managing eye pressure or intraocular pressure (IOP). By controlling IOP, it helps prevent and manage pressure-related issues, contributing to long-term optical health.

In summary, the discovery of PresVu is a significant development for patients with presbyopia. It opens new doors in the field of medical science and paves the way for further innovations in medication and treatment approaches in the future.

About Entod Pharmaceuticals Ltd.

Medisearch Laboratories Pvt. Ltd. (India), Entod Pharmaceuticals Ltd. (India), and our International Partners make up the Entod International Group. With more than 40 years of experience and specialised knowledge in pharmaceuticals, the Entod International Group of corporations is one of the top research-based, international pharmaceutical corporations.

Stay tuned for more updates…